Pacing-induced cardiomyopathy occurred in 14.1% of patients, with increased all-cause death or HF admission risk (54.0% vs. 38.3%, HR 2.93; P < 0.001).
Does the development of pacing-induced cardiomyopathy increase the risk of all-cause death or heart failure admission in patients with permanent pacemakers and initially preserved LVEF?
Pacing-induced cardiomyopathy occurs in approximately 14% of pacemaker patients with initially preserved LVEF and is associated with a nearly three-fold increased risk of death or heart failure admission.
Abstract Aims We investigated the clinical features, predictors, and long-term prognosis of pacing-induced cardiomyopathy (PiCM). Methods and results From a retrospective analysis of 1418 consecutive pacemaker patients, 618 were found to have a preserved baseline left ventricular ejection fraction (LVEF), follow-up echocardiographic data, and no history of heart failure (HF). PiCM was defined as a reduction in LVEF ( 50%) along with either (i) a ≥ 10% decrease in LVEF, or (ii) new-onset regional wall motion abnormality unrelated to coronary artery disease. PiCM occurred in 87 of 618 patients (14.1%), with a decrease in mean LVEF from 60.5% to 40.1%. The median time to PiCM was 4.7 years. Baseline left bundle branch block, wider paced QRS duration (≥ 155 ms), and higher ventricular pacing percentage (≥ 86%) were identified as independent predictors of PiCM in multivariate logistic regression analysis. The risk of PiCM increased gradually with the number of identified predictors, becoming more significant in the presence of two or more predictors (P 0.001). During the entire follow-up (median 7.2 years), the risk of all-cause death or HF admission was significantly higher in patients with PiCM compared to those without PiCM (38.3% vs. 54.0%, adjusted hazard ratio 2.93; 95% confidence interval 1.82–4.72; P 0.001). Conclusion Pacing-induced cardiomyopathy patients showed a worse long-term prognosis than those without PiCM. Therefore, patients with multiple risk factors of PiCM should be monitored carefully even if their left ventricular systolic function is preserved initially. A timely upgrade to a biventricular or His-bundle pacing device needs to be considered in patients with PiCM.
Cho et al. (2019) studied this question. Pacing-induced cardiomyopathy occurred in 14.1% of patients, with increased all-cause death or HF admission risk (54.0% vs. 38.3%, HR 2.93; P < 0.001).